Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Biomed Opt Express ; 14(10): 5499-5511, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-37854563

ABSTRACT

The total diffuse reflectance RT and the effective attenuation coefficient µeff of an optically diffuse medium map uniquely onto its absorption and reduced scattering coefficients. Using this premise, we developed a methodology where RT and the slope of the logarithmic spatially resolved reflectance, a quantity related to µeff, are the inputs of a look-up table to correct the dependence of fluorescent signals on the media's optical properties. This methodology does not require an estimation of the medium's optical property, avoiding elaborate simulations and their errors to offer accurate and fast corrections. The experimental demonstration of our method yielded a mean relative error in fluorophore concentrations of less than 4% over a wide range of optical property variations. We discuss how the method developed can be employed to improve image fidelity and fluorochrome quantification in fluorescence molecular imaging clinical applications.

2.
Int Ophthalmol ; 43(2): 363-370, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35864284

ABSTRACT

PURPOSE: To compare and analyze the interchangeability in measuring central corneal thickness (CCT) using ultrasonic pachymetry (USP, PACHMATE 2, DGH, Inc, Exton, PA, USA), non-contact specular microscopy (NCSM, CEM-530, Nidek CO, LTD, Gamagori, Japan) and a high-resolution Scheimpflug Camera (Pentacam HR, OCULUS, Wetzlar, Germany). METHODS: An observational, cross-sectional study was performed recruiting 216 volunteers, for a sample size of 216 eyes with no ocular abnormalities other than refractive errors. All subjects underwent pachymetric measurements obtained by USP, NCSM and Pentacam HR. Examinations were performed by the same examiner with USP always following the noncontact examinations. RESULTS: The mean CCT (± SD) was 560.30 ± 38.80 µm, 556.76 ± 36.83 µm and 547.31 ± 35.28 µm for USP, NCSM and Pentacam HR, respectively. The Bland-Altman analysis showed that the highest concordance was found between USP and NCSM, with differences between - 13.18 µm and 20.26 µm. For the differences between measurements obtained with Pentacam HR and USP, the differences at Bland-Altman plot were between - 28.25 and 13.57 µm. The lowest concordance was found for the CCT values measured with Pentacam HR and NCSM, with differences between - 25.67 and 6.86 µm. The intraclass correlation coefficient (ICC) between all pairs of measurements was between 0.979 and 0.987, suggesting that the mean measurements were strongly correlated. CONCLUSION: Measurements obtained with all three devices had high correlation. USP and NCSM were found in good agreement and high concordance, too. The above results indicate that these two devices are interchangeable in clinical practice. Pentacam HR may be a useful alternative for measuring CCT; however, it significantly underestimates CCT and cannot be used interchangeably with the other devices that we studied.


Subject(s)
Cornea , Microscopy , Humans , Microscopy/methods , Cross-Sectional Studies , Reproducibility of Results , Corneal Pachymetry
3.
J Appl Stat ; 49(3): 553-573, 2022.
Article in English | MEDLINE | ID: mdl-35706769

ABSTRACT

In this work, we develop and study upper and lower one-sided EWMA control charts for monitoring correlated counts with finite range. Often in practice, data of that kind can be adequately described by a first-order binomial or beta-binomial autoregressive model. Especially, when there is evidence that data demonstrate extra-binomial variation, the latter model is preferable than the former. The proposed charts can be used for detecting upward or downward shifts in process mean level. Practical guidelines concerning the statistical design of the proposed charts are given, while the effect of the extra-binomial variation is investigated as well. Comparisons with existing control charting procedures are also provided. Finally, an illustrative real-data example is also given.

4.
Medicina (Kaunas) ; 58(6)2022 May 30.
Article in English | MEDLINE | ID: mdl-35744006

ABSTRACT

Atrial fibrillation (AF) and Heart failure (HF) constitute two frequently coexisting cardiovascular diseases, with a great volume of the scientific research referring to strategies and guidelines associated with the best management of patients suffering from either of the two or both of these entities. The common pathophysiological paths, the adverse outcomes, the hospitalization rates, and the mortality rates that occur from various reports and trials indicate that a targeted therapy to the common background of these cardiovascular conditions may reverse the progression of their interrelating development. Among other optimal treatments concerning the prevalence of both AF and HF, the introduction of rhythm and rate control strategies in the guidelines has underlined the importance of sinus rhythm and heart rate control in the prevention of deleterious complications. The use of these strategies in the clinical practice has led to a debate about the superiority of rhythm versus rate control. The current guidelines as well as the published randomized trials and studies have not proved that rhythm control is more beneficial than the rate control treatments in the terms of survival, all-cause mortality, hospitalization rates, and quality of life. Therefore, the current therapeutic strategy is based on the therapy guidelines and the clinical judgment and experience. The aim of this review was to elucidate the endpoints of pharmacologic randomized clinical trials and the clinical data of each antiarrhythmic or rate-limiting medication, so as to promote their effective, individualized, evidence-based clinical use.


Subject(s)
Atrial Fibrillation , Heart Failure , Anti-Arrhythmia Agents/adverse effects , Atrial Fibrillation/complications , Atrial Fibrillation/drug therapy , Heart Failure/complications , Heart Failure/drug therapy , Heart Rate , Humans , Quality of Life
5.
Foods ; 10(6)2021 Jun 04.
Article in English | MEDLINE | ID: mdl-34199818

ABSTRACT

The influence of genetic (species, strain) and environmental (substrate) factors on the volatile profiles of eight strains of Pleurotus eryngii and P. ostreatus mushrooms cultivated on wheat straw or substrates enriched with winery or olive oil by products was investigated by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME-GC-MS). Selected samples were additionally roasted. More than 50 compounds were determined in fresh mushroom samples, with P. ostreatus presenting higher concentrations but a lower number of volatile compounds compared to P. eryngii. Roasting resulted in partial elimination of volatiles and the formation of pyrazines, Strecker aldehydes and sulfur compounds. Principal component analysis on the data obtained succeeded to discriminate among raw and cooked mushrooms as well as among Pleurotus species and strains, but not among different cultivation substrates. Ketones, alcohols and toluene were mainly responsible for discriminating among P. ostreatus strains while aldehydes and fatty acid methyl esters contributed more at separating P. eryngii strains.

6.
Vaccines (Basel) ; 10(1)2021 Dec 29.
Article in English | MEDLINE | ID: mdl-35062699

ABSTRACT

Kounis syndrome (KS) has been defined as acute coronary syndrome (ACS) in the context of a hypersensitivity reaction. Patients may present with normal coronary arteries (Type I), established coronary artery disease (Type II) or in-stent thrombosis and restenosis (Type III). We searched PubMed until 1 January 2020 for KS case reports. Patients with age <18 years, non-coronary vascular manifestations or without an established diagnosis were excluded. Information regarding patient demographics, medical history, presentation, allergic reaction trigger, angiography, laboratory values and management were extracted from every report. The data were pulled in a combined dataset. From 288 patients with KS, 57.6% had Type I, 24.7% Type II and 6.6% Type III, while 11.1% could not be classified. The mean age was 54.1 years and 70.6% were male. Most presented with a combination of cardiac and allergic symptoms, with medication being the most common trigger. Electrocardiographically, 75.1% had ST segment elevation with only 3.3% demonstrating no abnormalities. Coronary imaging was available in 84.8% of the patients, showing occlusive lesions (32.5%), vascular spasm (16.2%) or normal coronary arteries (51.3%). Revascularization was pursued in 29.4% of the cases. In conclusion, allergic reactions may be complicated by ACS. KS should be considered in the differential diagnosis of myocardial infarction with non-obstructive coronary arteries.

7.
J Biophotonics ; 13(6): e201960169, 2020 06.
Article in English | MEDLINE | ID: mdl-32134550

ABSTRACT

Perfusion and oxygenation are critical parameters of muscle metabolism in health and disease. They have been both the target of many studies, in particular using near-infrared spectroscopy (NIRS). However, difficulties with quantifying NIRS signals have limited a wide dissemination of the method to the clinics. Our aim was to investigate whether clinical multispectral optoacoustic tomography (MSOT) could enable the label-free imaging of muscle perfusion and oxygenation under clinically relevant challenges: the arterial and venous occlusion. We employed a hybrid clinical MSOT/ultrasound system equipped with a hand-held scanning probe to visualize hemodynamic and oxygenation changes in skeletal muscle under arterial and venous occlusions. Four (N = 4) healthy volunteers were scanned over the forearm for both 3-minute occlusion challenges. MSOT-recorded pathophysiologically expected results during tests of disturbed blood flow with high resolution and without the need for contrast agents. During arterial occlusion, MSOT-extracted Hb-values showed an increase, while HbO2 - and total blood volume (TBV)-values remained roughly steady, followed by a discrete increase during the hyperemic period after cuff deflation. During venous occlusion, results showed a clear increase in intramuscular HbO2 , Hb and TBV within the segmented muscle area. MSOT was found to be capable of label-free non-invasive imaging of muscle hemodynamics and oxygenation under arterial and venous occlusion. We introduce herein MSOT as a novel modality for the assessment of vascular disorders characterized by disturbed blood flow, such as acute limb ischemia and venous thrombosis.


Subject(s)
Spectroscopy, Near-Infrared , Tomography, X-Ray Computed , Humans , Muscle, Skeletal/diagnostic imaging , Perfusion , Pilot Projects
8.
IEEE Trans Biomed Eng ; 67(1): 185-192, 2020 01.
Article in English | MEDLINE | ID: mdl-30990172

ABSTRACT

OBJECTIVE: Fluorescence molecular imaging (FMI) has emerged as a promising tool for surgical guidance in oncology, with one of the few remaining challenges being the ability to offer quality control and data referencing. This paper investigates the use of a novel composite phantom to correct and benchmark FMI systems. METHODS: This paper extends on previous work by describing a phantom design that can provide a more complete assessment of FMI systems through quantification of dynamic range and determination of spatial illumination patterns for both reflectance and fluorescence imaging. Various performance metrics are combined into a robust and descriptive "system benchmarking score," enabling not only the comprehensive comparison of different systems, but also for the first time, correction of the acquired data. RESULTS: We show that systems developed for targeted fluorescence imaging can achieve benchmarking scores of up to 70%, while clinically available systems optimized for indocyanine green are limited to 50%, mostly due to greater leakage of ambient and excitation illumination and lower resolution. The image uniformity can also be approximated and employed for image flat-fielding, an important milestone toward data referencing. In addition, we demonstrate composite phantom use in assessing the performance of a surgical microscope and of a raster-scan imaging system. CONCLUSION: Our results suggest that the new phantom has the potential to support high-fidelity FMI through benchmarking and image correction. SIGNIFICANCE: Standardization of the FMI is a necessary process for establishing good imaging practices in clinical environments and for enabling high-fidelity imaging across patients and multi-center imaging studies.


Subject(s)
Optical Imaging , Phantoms, Imaging/standards , Molecular Imaging/instrumentation , Molecular Imaging/standards , Optical Imaging/instrumentation , Optical Imaging/standards , Reference Standards
9.
Sci Rep ; 9(1): 18123, 2019 12 02.
Article in English | MEDLINE | ID: mdl-31792293

ABSTRACT

Fluorescence imaging opens new possibilities for intraoperative guidance and early cancer detection, in particular when using agents that target specific disease features. Nevertheless, photon scattering in tissue degrades image quality and leads to ambiguity in fluorescence image interpretation and challenges clinical translation. We introduce the concept of capturing the spatially-dependent impulse response of an image and investigate Spatially Adaptive Impulse Response Correction (SAIRC), a method that is proposed for improving the accuracy and sensitivity achieved. Unlike classical methods that presume a homogeneous spatial distribution of optical properties in tissue, SAIRC explicitly measures the optical heterogeneity in tissues. This information allows, for the first time, the application of spatially-dependent deconvolution to correct the fluorescence images captured in relation to their modification by photon scatter. Using experimental measurements from phantoms and animals, we investigate the improvement in resolution and quantification over non-corrected images. We discuss how the proposed method is essential for maximizing the performance of fluorescence molecular imaging in the clinic.

10.
JACC Cardiovasc Interv ; 11(22): 2241-2250, 2018 11 26.
Article in English | MEDLINE | ID: mdl-30391389

ABSTRACT

OBJECTIVES: The aim of this study was to test the hypothesis that more intensive over standard anticoagulation administered during coronary angiography would significantly reduce rates of radial artery occlusion (RAO). BACKGROUND: RAO, although silent, remains a frequent and therefore worrisome complication following transradial coronary angiography. Anticoagulation is effective in reducing RAO, but the optimal heparin dose remains ill defined. METHODS: In this multicenter, randomized superiority trial, a high dose (100 IU/kg body weight administered in divided doses) and a standard dose (50 IU/kg body weight) of heparin during 5- or 6-F coronary angiography were compared. A total of 3,102 patients were randomized, of whom 1,836 patients not proceeding to percutaneous coronary intervention and without need for arterial access crossover entered the trial. Post-catheterization hemostasis did not follow a rigid protocol. RESULTS: A total of 102 early RAOs were found on ultrasonography (incidence 5.6%). In the high-dose heparin group, the rate of RAO was significantly lower compared with the standard-dose heparin group (27 [3.0%] vs. 75 [8.1%]; odds ratio: 0.35; 95% confidence interval: 0.22 to 0.55; p < 0.001), without compromising safety. The time to achieve hemostasis was similar between groups. To avoid 1 RAO, the number of patients needed to treat in the high-dose heparin group was approximately 20. These results were corroborated by our integrated database, showing an 80% reduction of forearm artery occlusions in high versus low heparin dose patients and our updated meta-analysis of randomized controlled trials demonstrating significant benefit of higher over lower anticoagulation intensity. CONCLUSIONS: High compared with standard heparin dose significantly reduced the rate of RAO in patients undergoing coronary angiography. High-intensity anticoagulation should be considered in transradial diagnostic procedures. (High [100IU/Kg] Versus Standard [50IU/Kg] Heparin Dose for Prevention of Forearm Artery Occlusion; NCT02570243).


Subject(s)
Arterial Occlusive Diseases/prevention & control , Catheterization, Peripheral , Coronary Angiography , Heparin/administration & dosage , Radial Artery , Aged , Anticoagulants/administration & dosage , Anticoagulants/adverse effects , Arterial Occlusive Diseases/diagnostic imaging , Arterial Occlusive Diseases/epidemiology , Catheterization, Peripheral/adverse effects , Coronary Angiography/adverse effects , Dose-Response Relationship, Drug , Female , Greece/epidemiology , Heparin/adverse effects , Humans , Incidence , Male , Meta-Analysis as Topic , Middle Aged , Prospective Studies , Radial Artery/diagnostic imaging , Time Factors , Treatment Outcome
11.
Angiology ; 69(9): 755-762, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29504410

ABSTRACT

Radial artery (RA) occlusion (RAO) remains the Achilles heel of transradial coronary procedures. Although of silent nature, RAO is relatively frequent, results in graft shortage for future coronary artery bypass surgery, and may occur even after short-lasting, 5F coronary angiography (CAG). The most frequent predictors of RAO are RA size, body size, female gender, and periprocedural anticoagulation intensity. Methods to detect RAO are variable, of which the Barbeau test and ultrasonography have similar diagnostic accuracy. Data indicate that late RAO recanalization may occur. Meticulous handling of RA and the use of appropriate hemostatic devices and techniques along with sufficient heparin dose appear important measures to reduce RAO rates. Recent contradictory studies indicate that the decreasing incidence of RAO overtime is not as uniform as previously thought. In 2 meta-analyses, the benefit of higher over lower anticoagulation intensity became evident. As "it may all be appropriate anticoagulation" for a simplified approach against RAO, the results of an ongoing trial comparing 100 with 50 IU/kg body weight in transradial CAG are eagerly awaited.


Subject(s)
Arterial Occlusive Diseases/etiology , Arterial Occlusive Diseases/prevention & control , Coronary Angiography/adverse effects , Percutaneous Coronary Intervention/adverse effects , Radial Artery , Vascular Patency , Humans
12.
Biomed Opt Express ; 8(7): 3395-3403, 2017 Jul 01.
Article in English | MEDLINE | ID: mdl-28717575

ABSTRACT

Label-free multispectral optoacoustic tomography (MSOT) has recently shown superior performance in visualizing the morphology of human vasculature, especially of smaller vessels, compared to ultrasonography. Herein, we extend these observations towards MSOT interrogation of macrovascular endothelial function. We employed a real-time handheld MSOT scanner to assess flow-mediated dilatation (FMD), a technique used to characterize endothelial function. A data processing scheme was developed to quantify the dimensions and diameter changes of arteries in humans and determine wall distensibility parameters. By enabling high-resolution delineation of the blood-vessel wall in a cross-sectional fashion, the findings suggest MSOT as a capable alternative to ultrasonography for clinical FMD measurements.

13.
J Phys Chem B ; 121(17): 4610-4619, 2017 05 04.
Article in English | MEDLINE | ID: mdl-28398066

ABSTRACT

Strontium borophosphate glasses of composition xSrO·(1 - x)·[0.68B2O3·0.32P2O5], 0.40 ≤ x ≤ 0.68, have been prepared by fast quenching of high-temperature melts and studied using Raman spectroscopy. In order to comprehend and confirm the obtained spectroscopic Raman data, crystalline compounds and glass-ceramics of analogous compositions were also prepared and studied. Also, ab initio molecular electronic structure theory was used to predict and confirm the experimental vibrational spectra The comparison between theoretical and experimental results showed a good overall agreement. The analysis has focused on a new detailed interpretation of the P-O-B Raman bands. Also, the analysis has revealed a divergent modification of the reported glasses near the meta-stoichiometry where the dominant species in the glass network were found to be borophosphate chains [BP2O9]5-, pyrophosphate P2O74-, and orthophosphate PO43- units.

14.
J Biomed Opt ; 22(1): 16009, 2017 01 01.
Article in English | MEDLINE | ID: mdl-28301638

ABSTRACT

Fluorescence molecular imaging (FMI) has shown potential to detect and delineate cancer during surgery or diagnostic endoscopy. Recent progress on imaging systems has allowed sensitive detection of fluorescent agents even in video rate mode. However, lack of standardization in fluorescence imaging challenges the clinical application of FMI, since the use of different systems may lead to different results from a given study, even when using the same fluorescent agent. In this work, we investigate the use of a composite fluorescence phantom, employed as an FMI standard, to offer a comprehensive method for validation and standardization of the performance of different imaging systems. To exclude user interaction, all phantom features are automatically extracted from the acquired epi-illumination color and fluorescence images, using appropriately constructed templates. These features are then employed to characterize the performance and compare different cameras to each other. The proposed method could serve as a framework toward the calibration and benchmarking of FMI systems, to facilitate their clinical translation.


Subject(s)
Benchmarking , Microscopy, Fluorescence/standards , Molecular Imaging/standards , Phantoms, Imaging/standards , Calibration , Microscopy, Fluorescence/instrumentation , Molecular Imaging/instrumentation , Optical Imaging
15.
J Biomed Opt ; 21(9): 091309, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27304578

ABSTRACT

Fluorescence imaging has been considered for over a half-century as a modality that could assist surgical guidance and visualization. The administration of fluorescent molecules with sensitivity to disease biomarkers and their imaging using a fluorescence camera can outline pathophysiological parameters of tissue invisible to the human eye during operation. The advent of fluorescent agents that target specific cellular responses and molecular pathways of disease has facilitated the intraoperative identification of cancer with improved sensitivity and specificity over nonspecific fluorescent dyes that only outline the vascular system and enhanced permeability effects. With these new abilities come unique requirements for developing phantoms to calibrate imaging systems and algorithms. We briefly review herein progress with fluorescence phantoms employed to validate fluorescence imaging systems and results. We identify current limitations and discuss the level of phantom complexity that may be required for developing a universal strategy for fluorescence imaging calibration. Finally, we present a phantom design that could be used as a tool for interlaboratory system performance evaluation.


Subject(s)
Molecular Imaging/instrumentation , Optical Imaging/instrumentation , Phantoms, Imaging , Fluorescent Dyes , Humans , Models, Biological , Polyurethanes
SELECTION OF CITATIONS
SEARCH DETAIL
...